Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

MAGENTA THERAPEUTICS, INC.

(MGTA)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su MAGENTA THERAPEUTICS, INC.
15/09MAGENTA THERAPEUTICS: Gets FDA Clearance for Leukemia Drug Trial, Plans Phase 1..
15/09Magenta Therapeutics Gets IND Clearance for MGTA-117
15/09MAGENTA THERAPEUTICS: Announces IND Clearance for MGTA-117 Targeted Conditionin..
15/09Magenta Therapeutics, Inc. Announces That Its Investigational New Drug Applic..
09/09TSCAN THERAPEUTICS: Names Zoran Zdraveski as Chief Legal Officer
12/08NORTH AMERICAN MORNING BRIEFING: Stock Futures -3-
05/08MAGENTA THERAPEUTICS: Management's Discussion and Analysis of Financial Conditi..
05/08Magenta Therapeutics, Inc. Reports Earnings Results for the Second Quarter En..
05/08MAGENTA THERAPEUTICS, INC.: Results of Operations and Financial Condition, Chan..
05/08Magenta Therapeutics, Inc. Announces Board Changes
05/08MAGENTA THERAPEUTICS: Reports Second Quarter Financial Results and Recent Progr..
04/08NORTH AMERICAN MORNING BRIEFING: Stock Futures -3-
03/08SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investor..
03/08Today on Wall Street: Corporate profits rise by a level not seen since 2009
03/08MAGENTA THERAPEUTICS: to Participate in Upcoming Healthcare Investor Conference..
03/08ANALYST RECOMMENDATIONS: Applied Industrials, Fastenal, Meggit, Planet Fitness,..
29/07SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investor..
27/07MAGENTA THERAPEUTICS, INC.: Results of Operations and Financial Condition (form..
22/07Health Care Up As Traders Seek Out Defensive Sectors -- Health Care Roundup
22/07SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investor..
21/07Magenta Therapeutics Shares Lower After FDA Clinical Hold Letter
21/07MAGENTA THERAPEUTICS: Early-Stage Trial of Leukemia Drug Put on Clinical Hold b..
21/07MAGENTA THERAPEUTICS: Announces Update on U.S. FDA Investigational New Drug App..
21/07Magenta Therapeutics Announces Update on U.S. FDA Investigational New Drug Ap..
21/07Magenta Therapeutics Gets FDA Clinical-Hold Letter
06/07MAGENTA THERAPEUTICS: Appoints Caren Deardorf as Chief Commercial Officer
06/07Magenta Therapeutics Appoints Caren Deardorf as Chief Commercial Officer
25/06MAGENTA THERAPEUTICS: Files Shelf for Up to 9.6 Million Common Shares on Behalf..
25/06MAGENTA THERAPEUTICS, INC.(NASDAQGM: MGTA) added to Russell 2000 Value-Defensiv..
25/06MAGENTA THERAPEUTICS, INC.(NASDAQGM: MGTA) added to Russell 2000 Defensive Inde..
25/06MAGENTA THERAPEUTICS, INC.(NASDAQGM: MGTA) added to Russell 2000 Growth-Defensi..
14/06MAGENTA THERAPEUTICS: Appoints Thomas Beetham as Chief Legal Officer
14/06Magenta Therapeutics Appoints Thomas Beetham as Chief Legal Officer
07/06MAGENTA THERAPEUTICS, INC.: Change in Directors or Principal Officers, Submissi..
07/06Magenta Therapeutics, Inc. Announces Resignation of Blake Byers from Board of..
07/06MAGENTA THERAPEUTICS: Announces additional preliminary positive results from on..
04/06MAGENTA THERAPEUTICS: Reports Additional Positive Data From Phase 2 Trial On MG..
04/06MAGENTA THERAPEUTICS: Announces Additional Preliminary Positive Results from On..
04/06Magenta Therapeutics Announces Additional Preliminary Positive Results from O..
03/06MAGENTA THERAPEUTICS: to Participate in Goldman Sachs 42nd Annual Global Health..
27/05MAGENTA THERAPEUTICS: Departure of Directors or Certain Officers; Election of D..
27/05MAGENTA THERAPEUTICS, INC.: Change in Directors or Principal Officers (form 8-K..
27/05Magenta Therapeutics, Inc. Announces Management Changes
14/05MAGENTA THERAPEUTICS: Announces $86.4 Million Common Stock Investment from Mult..
14/05MAGENTA THERAPEUTICS: to Participate in Upcoming Healthcare Investor Conference..
13/05MAGENTA THERAPEUTICS: MGTA-145 Ph2 MM Data Review Conference Call Presentation
12/05MAGENTA THERAPEUTICS, INC.: Entry into a Material Definitive Agreement, Unregis..
12/05MAGENTA THERAPEUTICS: Selling $86.4 Million in Common Shares To Institutional I..
12/05MAGENTA THERAPEUTICS: Mid-Stage Multiple Myeloma Study Meets Primary Endpoint; ..
12/05MAGENTA THERAPEUTICS: Announces $86.4 Million Common Stock Investment from Mult..
12/05MAGENTA THERAPEUTICS: Announces Positive Preliminary Results from Phase 2 Clini..
12/05Magenta Therapeutics Announces Positive Preliminary Results from Phase 2 Clin..
07/05MAGENTA THERAPEUTICS: Reports First Quarter Financial Results
06/05MAGENTA THERAPEUTICS: Management's Discussion and Analysis of Financial Conditi..
06/05MAGENTA THERAPEUTICS, INC.: Results of Operations and Financial Condition, Fina..
06/05MAGENTA THERAPEUTICS: Reports First Quarter Financial Results and Recent Progra..
06/05Magenta Therapeutics, Inc. Reports Earnings Results for the First Quarter End..
19/04MAGENTA THERAPEUTICS: Appoints David Nichols as Chief Technical Officer
19/04Magenta Therapeutics Appoints David Nichols as Chief Technical Officer
26/03MAGENTA THERAPEUTICS: to Participate in the Guggenheim Healthcare Talks 2021 Ge..
25/03MAGENTA THERAPEUTICS: to Participate in the Guggenheim Healthcare Talks 2021 Ge..
25/03PRESS RELEASE: Heidelberg Pharma announces financial figures for fiscal year 20..
16/03MAGENTA THERAPEUTICS: Presents Final Phase 1 Results
15/03MAGENTA THERAPEUTICS: Presents Final Phase 1 Results of MGTA-145 Stem Cell Mobi..
15/03Magenta Therapeutics Presents Final Phase 1 Results of MGTA-145 Stem Cell Mob..
09/03MAGENTA THERAPEUTICS: to Present at the Oppenheimer 31st Annual Healthcare Conf..
03/03MAGENTA THERAPEUTICS: Reports Narrower Q4 Loss
03/03MAGENTA THERAPEUTICS: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
03/03Magenta Therapeutics, Inc. Reports Earnings Results for the Full Year Ended D..
03/03MAGENTA THERAPEUTICS, INC.: Results of Operations and Financial Condition, Fina..
03/03MAGENTA THERAPEUTICS: Reports Fourth Quarter and Full-Year 2020 Financial Resul..
09/02MAGENTA THERAPEUTICS: to Present Additional Data from Phase 1 MGTA-145 Stem Cel..
08/02MAGENTA THERAPEUTICS: to Present Additional Data from Phase 1 MGTA-145 Stem Cel..
11/01MAGENTA THERAPEUTICS, INC.: Results of Operations and Financial Condition, Fina..
11/01MAGENTA THERAPEUTICS: Highlights Recent Progress and Expected Timing of 2021 Mi..
1  2  3  4Pross.
Prossimo evento su MAGENTA THERAPEUTICS, INC.
11/11/21